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Abstract 17 
Methicillin-resistant Staphylococcus aureus LVDµVXSHUEXJ¶UHVSRQVLEOHIRUH[WHQVLYHGHDWK18 
and morbidity. Chronic S. aureus infections are associated with the presence of intracellular 19 
bacteria and the host cytosol is an aerobic low redox potential (Eh) environment. How S. 20 
aureus adapts to aerobic low Eh environments is understudied. A low external Eh, imposed 21 
by the non-metabolizable reductant dithiothreitol, resulted in transcriptional reprogramming 22 
mediated by the redox-responsive transcription factors AgrA, Rex and SrrBA resulting in a 23 
shift towards fermentative metabolism. Accordingly, in the presence of the host cytoplasmic 24 
reductant glutathione S. aureus aerobic respiration was impaired, the intracellular 25 
NADH:NAD+ ratio increased, lactate dehydrogenase was induced, resistance to the 26 
aminoglycoside antibiotic gentamicin was enhanced and greater numbers of small colony 27 
variants (SCVs) were detected. These observations suggest that entry of S. aureus into the 28 
aerobic low Eh environment of the host cytosol could result in adaptive responses that 29 
promote the formation of SCVs.  30 
 31 
INTRODUCTION 32 
Methicillin-resistant Staphylococcus aureus, such as S. aureus 86$-(LVDµVXSHUEXJ¶33 
that is resistant to a range of clinical antibiotics and a major healthcare problem. It is an 34 
adaptable bacterium with a formidable armoury of virulence factors leading to a range of 35 
clinical syndromes, including bacteremia, toxic shock syndrome, meningitis and pneumonia 36 
[1]. Chronic, recurrent infections are often characterized by the presence of slow growing, 37 
antibiotic-resistant small colony variants (SCVs) that have been associated with invasion of, 38 
and survival within, non-professional phagocytes [2-10]. Stable (genotypic) SCVs are often 39 
characterized by mutations in genes required for menaquinone or haem biosynthesis and 40 
consequently exhibit impaired respiratory metabolism, resulting in phenotypes resembling 41 
those observed in hypoxic environments [11]. Secondary mutations that constitutively 42 
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activate the redox-sensing two-component system SrrBA, which plays a major role in 43 
adaption to hypoxic environments, permits stable SCVs to retain drug-resistance whilst 44 
regaining the capacity for rapid growth [11]. In contrast, phenotypic SCVs are unstable and 45 
revert to normal growth rates with loss of antibiotic resistance, suggesting a reversible 46 
mechanism that avoids the permanent fitness costs of genotypic resistance [12]. Adoption of 47 
the SCV phenotype within the confines of a host cell and reversion to wild-type virulence 48 
traits within 24 h of liberation is thought to be a mainstream component of the process 49 
leading to chronic infections [9,10]. 50 
The redox potential (Eh) of host cell cytoplasm is low (-220 to -285 mV) due the presence of 51 
high (30:1 to 100:1) ratios of reduced glutathione (GSH) to oxidized gluthathione (GSSG) 52 
[13].  It is clear that S. aureus can survive and replicate in the host intracellular milieu 53 
[9,10,14].  Therefore, the work reported here was undertaken to begin to improve  54 
understanding of how S. aureus adapts to an aerobic low Eh environment, such as might be 55 
encountered in the host cytosol. It is suggested that low Eh prompts S. aureus transcriptional 56 
reprogramming mediated by redox-responsive transcription regulators, including Agr, Rex 57 
and SrrA, resulting in induction of fermentative metabolism, lower growth rates, resistance to 58 
aminoglycoside antibiotics and enhanced formation of SCVs. Hence adaptation to the low Eh 59 
of the host cytosol could contribute to establishing and maintaining persistent infections. 60 
METHODS 61 
General culture conditions 62 
The bacterial strains used were: S. aureus USA300 JE2 and the S. aureus USA300 JE2 rex 63 
mutant from the Nebraska Tn library [15]; S. aureus RN4220 was the host for the ldh1-gfp 64 
plasmid pGS2625 (see below) [16]. Standard culture conditions and growth media were as 65 
described in Sambrook and Russell [17]. Appropriate antibiotics were added from sterile 66 
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stock solutions.  Overnight liquid cultures were prepared from single colonies transferred into 67 
5 ml of liquid medium (Brain Heart Infusion broth, Tryptic Soy broth or Luria-Bertani broth) 68 
and incubated at 37oC with shaking (250 rpm). To estimate bacterial growth, optical density 69 
was measured at 600 nm (OD600) using an ATI Unicam spectrophotometer. To measure 70 
viable bacterial cells, suspensions were serially diluted 1:10 in phosphate-buffered saline in 71 
triplicate and then 10 µl of each dilution was spotted onto solid medium. The dried agar 72 
plates were incubated at 37oC overnight and the number of colony forming units (CFUs) was 73 
counted.   74 
*URZWKLQOLTXLGPHGLDZDVDOVRPRQLWRUHGXVLQJD6XQULVHPLFURSODWHUHDGHU7(&$175 
An overnight starter culture was diluted 1:50 into 50 ml fresh medium, as indicated for each 76 
experiment, and after 3 h at 37oC with shaking (250 rpm) the culture was diluted to OD600 77 
0.0125 in 200 µl fresh medium (supplemented as indicated in the text) in the wells of a 96 78 
well plate (Thermo Scientific). The plates were incubated at 37oC in the microplate reader 79 
with shaking, where OD600 was recorded every 15 min by the Magellan 7.1 software 80 
(TECAN). 81 
Continuous cultures 82 
A single colony of S. aureus USA300 JE2 was used to inoculate 5 ml Brain Heart Infusion 83 
broth for incubation overnight at 37oC with shaking (250 rpm). This culture was then injected 84 
into a 2 l Labfors chemostat vessel (Infors-HT, Switzerland) containing 1 l of chemically 85 
defined medium with 15 mM glucose as the sole source of carbon and 0.0001% (v/v) 86 
Antifoam Y-30 Emulsion (Sigma-Aldrich) [18].  The culture was grown under batch 87 
FRQGLWLRQVIRUíKEHIRUHEHLQJVZLWFKHGWRFRQWLQXRXVFXOWXUHZLWKDGLOXWLRQUDWHRI88 
h-1. Positive dissolved oxygen concentrations were maintained by constant addition of filtered 89 
air (1 l min-1) and agitation (400 rpm). Temperature (37oC) and pH (7.0) were maintained 90 
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throughout the experiments. Redox potential (Eh) was measured using an ORP FermProbe 91 
%URDGO\ -DPHV DFFRUGLQJ WR WKHPDQXIDFWXUHU¶V LQVWUXFWLRQV$Q(h of 86 mV was set by 92 
using a pH 7.0 Quinhydrone-buffered solution and an Eh of 263 mV was set by using a pH 93 
4.0 Quinhydrone-buffered solution.  94 
The aerobic steady-state cultures were perturbed by addition of 9.7 mM (final concentration) 95 
dithiothreitol (DTT) directly to the culture and the feed supply. Samples, for transcript 96 
profiling, enzyme assays, optical density measurements (OD600) and 1H-NMR measurements 97 
of exo-metabolites, were taken at 0, 2, 5, 10, 15, 30, 60 and 1440 min following the addition 98 
of DTT. 99 
Samples for RNA isolation were taken by collection directly into 2 volumes of RNAprotect 100 
Bacteria Reagent (QIAgen). These were immediately mixed (vortexed for 5 s) and then 101 
incubated at room temperature for 5 min before centrifugation (4oC) for 10 min at 3,380 xg. 102 
The supernatant was then poured off and the pellet suspended in the residual solution. The 103 
suspended sample was then transferred to a 1.5 ml micro-centrifuge tube and centrifuged for 104 
10 min at 20,000 xg EHIRUHUHPRYLQJWKHVXSHUQDWDQWDQGVWRULQJWKHSHOOHWDWíoC. 105 
Samples (5 ml) for culture medium analysis were centrifuged (4oC) for 10 min at 3,380 xg. 106 
The supernatant was passed through a 0.22 µm syringe filter and two 1.5 ml samples were 107 
stored in micro-FHQWULIXJHWXEHVDWíoC. 108 
Samples for enzyme assays were collected at 0, 60 and 1440 min following the addition of 109 
DTT. Two 50 ml culture samples were collected in two 50 ml tubes and centrifuged in a 110 
cooled centrifuge (4oC) for 10 min at 3,380 xg. The supernatants were poured off and the 111 
VDPSOHVVWRUHGDWíoC. 112 
Transcript profiling 113 
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A custom Agilent microarray was designed using eArray (www.earray.chem.agilent.com). It 114 
contained probes for S. aureus USA300_FPR3757 and S. aureus N8325 (Agilent Design ID: 115 
066358). RNA labelling was achieved using 8 µg of purified RNA in 6.15 µl molecular 116 
biology grade water and 2.5 µg of random primers (Invitrogen). This mixture was incubated 117 
for 10 min at 72oC and then placed on ice for 10 min. Addition of 6.25 µl reverse 118 
transcription mix (5x First strand buffer, 3.0 µl; 0.1 M DTT, 1.5 µl; 50x dNTP mix, 0.3 µl 119 
(dNTP mix contained 25 mM dATP, dTTP, dGTP and 10 mM dCTP) and molecular biology 120 
grade water, 1.45 µl) followed by 1 µl 1 mM Cy5-dCTP (or Cy3-dCTP for the time 0 min 121 
reference samples) (GE Healthcare) and 0.75 µl SuperScript III reverse transcriptase (200 U 122 
µl-1, Invitrogen). The samples were incubated for 5 min at 25oC then overnight at 50oC before 123 
addition of 7.5 µl 0.1 M NaOH and incubation for 10 min at 72oC, followed by addition of 124 
7.5 µl of 0.1 M HCl. The samples were purified using PCR purification kit (Qiagen) and the 125 
concentration of cDNA and labellLQJ HIILFLHQF\ ZDV PHDVXUHG XVLQJ D 1DQRGURS 1'-126 
1000 Spectrophotometer, Peqlab Ltd). Hybridization and washing were carried out according 127 
WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV $JLOHQW 7ZR-Color Microarray-Based Prokaryotic 128 
Analysis (Fairplay III Labeling) Protocol). Cy5-labelled cDNA (300 ng) from the test sample 129 
was hybridized in tandem with 300 ng of Cy3-labelled cDNA from the 0 min (initial steady-130 
state) sample. The array slides were incubated at 65oC for 17 h in a Hybridisation Oven 131 
(Agilent).  Slides were scanned in an Agilent Microarray Scanner and data were extracted 132 
from .tif files using Agilent Feature Extraction 11.5.  Data were analyzed using Agilent 133 
GeneSpring 7.3.1. Signal intensities for each array were divided by the signal obtained from 134 
the control channel (Cy3-labelled time point 0 min) with a median shift being applied across 135 
DOOVDPSOHV LQFOXGHG LQHDFKFRPSDULVRQ $6WXGHQW¶V W-test (2 tailed, equal variance) with 136 
Benjamini-Hochberg correction was applied to the data. The complete gene expression data 137 
are available in ArrayExpress accession number E-MTAB-6942. 138 
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The TFinfer software was used to infer changes in the activities of 11 S. aureus transcription 139 
factors (AirR, AgrA, CstR, CymR, MgrA, NreABC, Rex, Rot, SarA, SarZ and SrrA) [19].  140 
TFInfer is a state space model representing a simplified version of transcription based on a 141 
linear approximation (in log space) to the dynamics of transcription and treats noise in a 142 
principled way such that the estimated TF activities are associated with confidence limits 143 
[19].  The model was implemented using a connectivity matrix linking the 11 S. aureus 144 
transcription factors listed above to genes present in their regulons as identified by transcript 145 
profiles of parent and mutant strains and the time-resolved gene expression data for all the 146 
genes present in the connectivity matrix.  147 
Detection of small colony variants (SCVs) 148 
A single colony of S. aureus USA300 JE2 or the isogenic rex mutant from the Nebraska Tn 149 
mutant library [15] (confirmed by PCR) was used to inoculate 5 ml of Tryptic Soy broth and 150 
then incubated overnight at 37oC with shaking (250 rpm). This culture was used to inoculate 151 
50 ml fresh medium to OD600 0.05. After 3 h incubation at 37oC with shaking (250 rpm) GSH 152 
(10 mM) was added and the culture was incubated for a further hour. Then the culture was 153 
serially diluted 1:10 in triplicate and 10 µl spotted onto plates (Tryptic Soy agar) with and 154 
without GSH (10 mM) and with and without gentamicin (2 µg ml-1).  After 48 h the colony 155 
forming units were counted and the SCVs were assigned based on appearance: small (~10th 156 
size of wild-type colonies), light-coloured (white or pale yellow as compared to orange wild-157 
type colonies) and gentamicin-resistant. 158 
Lactate dehydrogenase assay 159 
Aliquots of cell-free extracts (~20 ng protein) were added to 35 mM Tris-HCl, pH 7.9 160 
containing 1 mM MnSO4 and 0.15 mM NADH and absorbance at 340 nm was monitored 161 
using a spectrophotometer at 37°C.  After establishing a base rate, pyruvate (5 mM) was 162 
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added and the oxidation of NADH was monitored at 340 nm. The specific activity of lactate 163 
dehydrogenase was calculated in µmol NADH oxidized mg-1 h-1 using a molar extinction 164 
coefficient for NADH of 6,220 M-1 cm-1.  165 
Construction and assay of a ldh1-gfp promoter fusion plasmid 166 
The intergenic region between ldh1 and the divergent SAUSA300_0234 gene was amplified 167 
from genomic DNA using PCR primers containing KpnI and HindIII restriction enzyme sites.  168 
The PCR product and the reporter plasmid, pCM20, which contains the S. aureus nuc 169 
promoter fused to superfolder gfp, were digested with KpnI and HindIII to release the nuc 170 
promoter from pCM20 and prepare the ldh1 promoter region for ligation upstream of gfp 171 
[20].  After gel purification (Qiagen Gel Extraction kit), the ldh1 promoter and the pCM20 172 
plasmid backbone were ligated.  The ligation mixes were used to transform competent E. coli 173 
cells and the transformants were selected by plating on agar plates containing ampicillin (100 174 
Pg ml-1).  The authenticity of the construct (pGS2625) was confirmed by DNA sequencing 175 
before transferring the plasmid to S. aureus RN2440 by selecting for growth on erythromycin 176 
(4 Pg ml-1).   177 
Pyruvate dehydrogenase assay 178 
Pyruvate dehydrogenase complex activity was estimated by measuring the rate of depletion 179 
of CoASH in a discontinuous assay. Cell extracts of bacteria grown as Brain Heart Infusion 180 
broth batch cultures were prepared by two passages through a French pressure cell.  A 181 
reaction mixture containing buffer (31 mM Tris-HCl, pH 8.5), thiamine pyrophosphate (0.33 182 
mM), cell-free extract, CoASH (0.08 mM), NAD+ (3 mM) and NADH (0-3 mM) was 183 
prepared. The reaction was initiated with the addition of pyruvate (11.5 mM) and stopped 184 
after 10 min using 10% SDS before adding 5, 5´ dithiobis(2-nitrobenzoate) (DTNB) (0.04%). 185 
The amount of CoASH remaining was calculated by measuring absorbance at 412 nm on an 186 
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ATI Unicam UV/VIS spectrophotometer using the molar extinction coefficient for 2-187 
nitrothiobenzoate (13,700 M-1 cm-1). 188 
Respiration rate measurements 189 
Oxygen uptake rates at 37oC of washed cell suspensions were measured using a Clark-type 190 
oxygen electrode (Rank Bros Ltd). Overnight cultures were diluted 1:50 in 50 ml fresh 191 
medium incubated for 3 h at 37oC with shaking (250 rpm) to produce log phase cultures. 192 
These bacteria were collected by centrifugation (4oC) for 10 min at 3,380 xg. The cell pellets 193 
were suspended in pre-cooled 0.02 M phosphate-buffered saline and centrifuged in a cooled 194 
centrifuge (4oC) for 10 min at 3,380 xg twice before the resulting washed cell pellets were 195 
suspended in pre-cooled 0.02 M phosphate-buffered saline to a final optical density (OD600) 196 
of 50. Aliquots (50 Pl) of the cell suspension were added to phosphate-buffered saline (1950 197 
µl) and after the baseline rate of oxygen uptake was established, glucose (2.5 mM final 198 
concentration) was injected. After 1 min either a control of 50 µl 0.02 M phosphate-buffered 199 
saline was added or 50 µl KCN (final concentration 25 mM) or GSH (final concentration 10 200 
mM). Respiration rates (nmol O2 min-1 OD600-1) were then calculated. 201 
 Growth inhibition zone assay 202 
An overnight culture was diluted 1:100 in 20 ml of molten (50oC) soft agar (0.7% agar) 203 
Tryptic Soy medium. This was then poured onto 20 ml solid Tryptic Soy medium and left to 204 
cool before a sterile 6 mm filter paper disc was placed on top. The disc was loaded with 20 µl 205 
of gentamicin (50 mg ml-1) and the plates were incubated at 37oC overnight under aerobic or 206 
anaerobic (anaerobic jars which contained an Oxoid AnaeroGen 2.5 L sachet) conditions 207 
before measurement of the growth inhibition zone. In other experiments Tryptic Soy medium 208 
was replaced by chemically defined medium with and without nitrate (10 mM) [18]. 209 
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Measurement of NADH:NAD+ ratios 210 
A single colony from solid medium was used to inoculate a 5 ml chemically defined medium 211 
supplemented with 10% Luria-Bertani broth overnight at 37°C with shaking (250 rpm). This 212 
was used to inoculate the same medium (50 ml), which was incubated (37°C, 250 rpm 213 
shaking) to OD600 ~1.0. Two samples (5 ml) were removed from the culture and GSH (10 214 
mM) was added to the culture, which was incubated for a further hour before taking further 5 215 
ml samples. All samples taken were immediately placed within pre-cooled (-80°C) 50 ml 216 
tubes. The cells were collected by centrifugation and washed in M9 salts before storing at -217 
20°C. For NAD+ extraction, pellets were suspended in 0.2 M HCl and sonicated for two 30 s 218 
bursts. The sample was then centrifuged, the pellet was discarded and the supernatant was 219 
neutralized with 0.2 M NaOH. The same method was employed for NADH extraction, except 220 
that 0.2 M NaOH was initially added to suspend the cell pellets before sonication and 0.2 M 221 
HCl was used to neutralize the supernatant after centrifugation. The cell extracts obtained 222 
were then used in the coupled assay of Bernofsky and Swan [21].  Reactions contained: 0.144 223 
M glycylglycine, pH 7.0; 0.035% ethanol; 2.4 mM phenazine ethosulfate; 0.6 mM 224 
methylthiazolyldiphenyl-tetrazolium bromide; 500 Pl cell-extract; and H2O to 995 Pl.  225 
Reaction mixtures were left to equilibrate in the dark for 20 min before being started with the 226 
addition of yeast alcohol dehydrogenase (5 Pl; 9-18 units Pl; Roche).  The reactions were 227 
followed spectrophotometrically at 570 nm. 228 
  229 
RESULTS AND DISCUSSION 230 
An aerobic low Eh environment induces fermentative metabolism in cultures of 231 
S. aureus USA300 JE2 232 
11 
 
In the first phase of this work the non-metabolizable reducing agent dithiothreitol (DTT; Eh -233 
330 mV at pH 7.0) was used to isolate the effects of low external Eh from other potentially 234 
confounding factors that might arise from using a metabolically active physiological 235 
reductant. Aerobic steady-state chemostat cultures of S. aureus USA300 JE2 (triplicate 236 
independent cultures; pH 7.0, dilution rate 0.2 h-1, dissolved O2 in the medium t10%) were 237 
established. After baseline sampling, the steady-states were perturbed by introducing DTT 238 
(9.7 mM) to mimic the low external Eh in the aerobic but reducing environment of the host 239 
cell cytoplasm (the maximum growth rate of S. aureus USA300 JE2 in batch cultures 240 
containing 9.7 mM DTT was greater than the growth rate set by the dilution rate of the 241 
chemostat; Fig. S1). The external Eh of the initial steady-state cultures was 60 r14 mV, 242 
similar to previous reports (~50 mV) [22], but after addition of DTT rapidly decreased to a 243 
final value of ~-275 r40 mV (Fig. 1a). The dissolved O2 concentration in the culture 244 
increased rapidly after DTT addition, before returning to the pre-perturbation value at 30 min 245 
consistent with a transient decrease in respiration rate (Fig. 1b). After perturbation the 246 
concentration of excreted lactate increased ~6-fold from ~1 mM to 6.2 r0.1 mM in the new 247 
low Eh steady-state, indicating that ~20% of glucose carbon supplied was converted to lactate 248 
under these new conditions (Fig. 1c). Accordingly, the lactate dehydrogenase activity of cell-249 
free extracts increased ~6-fold after 60 min and ~14-fold 1440 min after exposure to DTT 250 
(Fig. 1d). These data suggest that when S. aureus enters a low Eh aerobic environment, 251 
aerobic respiration is transiently inhibited (manifest as a decrease in O2 consumption) and 252 
aerobic respiratory metabolism and fermentation co-exist (respiro-fermentative growth). 253 
 254 
An aerobic low Eh environment triggers S. aureus USA300 JE2 transcriptional 255 
reprogramming consistent with a shift to respiro-fermentative metabolism 256 
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The dynamics of S. aureus USA300 JE2 gene expression in response to perturbation of the 257 
external redox state were measured by time-resolved transcript profiling (Table 1). TFInfer is 258 
a state space model that reveals the changes in transcription factor activities that drive 259 
transcriptional reprogramming [19]. A connectivity matrix was assembled for 11 S. aureus 260 
transcription factors (AirR, AgrA, CstR, CymR, MgrA, NreABC, Rex, Rot, SarA, SarZ and 261 
SrrA) that have previously been associated with redox-sensing and/or persistence [23-32].  262 
Inference of the activities of these 11 transcription factors predicted that Rex and SrrA 263 
exhibited the greatest changes (t7-fold, t90% confidence; Fig. 1e). DNA-binding by Rex is 264 
impaired when the NADH:NAD+ ratio is high, resulting in derepression of genes associated 265 
with anaerobic metabolism. A reduced quinone pool activates the SrrBA two-component 266 
system resulting in activation of genes involved in anaerobic metabolism, cytochrome and 267 
heam biosynthesis and down-regulation of agr-RNAIII. This is consistent with the strong 268 
induction of transcripts associated with anaerobic metabolism: pflBA, ldh1, adh, narG, and 269 
ddh (Table 1).  Previous work has shown enhanced abundance of fermentative enzymes 270 
pyruvate formate lyase (PflB), alcohol dehydrogenase (Adh), D- and L-lactate 271 
dehydrogenases (Ddh, Ldh1, Ldh2; the latter being maximally up-regulated 9.1-fold in 272 
response to DTT and hence just below the 10-fold cut-off applied to genes listed in Table 1) 273 
[33]. Moreover, S. aureus Newman strain ldh1 and ldh1-ldh2 double mutants are 274 
significantly attenuated in a mouse model of infection [34]. Taken together these analyses 275 
suggest that redox-sensing and induction of fermentative metabolism are important factors 276 
for intracellular survival of S. aureus.  277 
The TFInfer analysis also suggested that AgrA activity decreased under low Eh 278 
conditions, manifest as severe down-regulation of the agr locus and lower expression of 279 
psmB1, psmB2 and hld (Fig. 1e; Table 1). Down-regulation of the Agr-activated psmB1 and 280 
psmB2, coding for the phenol soluble modulins PSMB1 and PSMB2, is a major factor in S. 281 
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aureus persister formation, and the G-toxin (hld, PSMJ) is implicated in phagosome escape 282 
[35,36].  283 
 284 
The host cytoplasmic reductant glutathione increases the frequency of S. 285 
aureus USA300 JE2 SCVs and enhances resistance to gentamicin 286 
The experiments using DTT as an extracellular reductant indicated that S. aureus USA300 287 
JE2 responded to an aerobic low Eh environment by adopting respiro-fermentative 288 
metabolism.  The host cytosol is an aerobic low Eh environment maintained by the reductant 289 
GSH. The experiments using DTT suggested that exposing S. aureus USA300 JE2 to GSH 290 
(10 mM) would result in impaired respiration and this was found to be the case (Fig. 2a). 291 
Impairment of respiration was found to be associated with higher NADH:NAD+ ratios (Fig. 292 
S2).  Higher NADH:NAD+ ratios are known to inhibit pyruvate dehydrogenase (PDHC) 293 
activity in several bacterial species and measurement of S. aureus USA300 JE2 PDHC 294 
activity showed that it was also inhibited at elevated NADH:NAD+ ratios (Fig. S3) [37].  295 
Consistent with these observations and the enhanced expression of ldh1 after perturbation of 296 
the chemostat cultures by DTT (Table 1), expression of Green fluorescent protein from a 297 
plasmid borne (pGS2625) ldh1-gfp fusion in S. aureus RN4220 was increased in the presence 298 
of GSH (Fig. 2b).  This is interpreted as indicating sensing of increased NADH:NAD+ ratio 299 
by the transcription factor Rex leading to derepression of ldh1 and consequent reduction of 300 
pyruvate to lactate. 301 
A S. aureus membrane electrical potential ('<) of -75 to -95 mV is required for uptake of the 302 
aminoglycoside antibiotic gentamicin [38].  Bacteria adopting respiro-fermentative 303 
metabolism are likely to have a lower '< compared to those utilizing aerobic respiration and 304 
therefore the resistance of S. aureus USA300 JE2 to gentamicin was tested in the presence of 305 
GSH. Addition of GSH to the culture medium allowed S. aureus USA300 JE2 to grow in the 306 
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presence of gentamicin (Fig. 2c). The ionophore, nigericin, is capable of restoring '< at the 307 
expense of the transmembrane proton gradient.  Addition of nigericin to low Eh cultures of S. 308 
aureus USA300 JE2 partially restored sensitivity to gentamicin (Fig. 2d). The increased 309 
resistance to gentamicin in the presence of GSH is therefore likely caused by a decrease in 310 
'<.  Accordingly, gentamicin tolerance correlated with the Eh of the electron acceptor being 311 
used to support growth, i.e.  S. aureus USA300 JE2 growing by aerobic respiration was less 312 
tolerant to gentamicin than when growing by anaerobic (nitrate) respiration or by anaerobic 313 
fermentation and this aerobic sensitivity was much diminished in the presence of GSH (Fig. 314 
2e and f). 315 
As noted above, S. aureus SCVs are induced by the host intracellular environment in which 316 
the bacteria are exposed to the cytoplasmic reductant GSH. Plating S. aureus USA300 JE2 317 
under aerobic conditions in the presence of GSH resulted in a significant increase in the 318 
number of SCVs, suggesting that the adaptations initiated by perception of the low Eh signal 319 
contribute establishing the SCV phenotype (Fig. 2g; closed bars).  One plausible explanation 320 
for the increased frequency of S. aureus USA300 JE2 SCVs in the presence of GSH was that 321 
mutation rates were greater under reducing conditions.  However, measurements indicated 322 
that there was no significant difference (2-tailed T-test p= 0.39) in the frequencies of 323 
rifampicin (100 Pg ml-1) resistant mutants in the absence (1.3 x 10-7 r 0.7 x 10-7; n=3) or 324 
presence (6.8 x 10-8 r3.8 x 10-8; n=3) of GSH (10 mM). 325 
The transcriptional profiling and associated prediction of transcription factor activities 326 
indicated major changes in the regulation of the Rex regulon under low Eh conditions (Table 327 
1).  Therefore, SCV formation by the S. aureus USA300 JE2 rex mutant, from the Nebraska 328 
Tn library, was measured in the presence and absence of GSH.  The frequency of rex mutant 329 
SCVs from cultures pre-exposed to GSH (10 mM) was similar to that of unexposed cultures 330 
when plated on Tryptic Soy agar containing gentamicin (2 Pg ml-1) (Fig. 2f, open bars) and 331 
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greater than that observed for the parent strain.  When the rex mutant was spread on plates 332 
containing gentamicin (2 Pg ml-1) and GSH (10 mM) bacterial lawns were observed for both 333 
pre- and un-treated cultures, suggesting that in the presence of GSH the rex mutant exhibits 334 
increased resistance to gentamicin.  Accordingly, the frequency of rex mutant SCVs in the 335 
presence of GSH (10 mM) and a higher concentration of gentamicin (10 Pg ml-1) was greater 336 
than that observed when the plates contained the standard concentration of gentamicin (2 Pg 337 
ml-1) and no GSH (Fig. 2f, open bars).  It was concluded that derepression of anaerobic 338 
metabolism by deletion of rex enhances SCV formation and that the rex mutant exhibits 339 
enhanced tolerance to gentamicin in the presence of GSH compared to the parent strain under 340 
these conditions.   341 
These data suggested that GSH increased the frequency of S. aureus USA300 JE2 SCVs 342 
without significantly increasing the frequency of general mutation.  Therefore, phenotypic 343 
stability of S. aureus USA300 JE2 SCVs in the absence and presence of GSH (10 mM) was 344 
determined.  Small colony variants were first generated by plating aliquots of overnight 345 
Tryptic Soy broth cultures on Tryptic Soy agar supplemented with gentamicin (2 Pg ml-1) and 346 
incubating at 37°C for 48 h [39].  Small colony variants were picked and sequentially patched 347 
onto Tryptic Soy agar supplemented with GSH (10 mM) and unamended Tryptic Soy agar.  348 
After incubation at 37°C for 3 days the patches were scored as unstable, mixed or stable as 349 
defined by Edwards [39] (Fig. S4).  Examination of 210 SCVs indicated that 66 of these 350 
acquired a mixed phenotype when plated on Tryptic Soy agar but retained a stable SCV 351 
phenotype on Tryptic Soy agar containing GSH (Table 2).  Thirteen SCVs with an unstable 352 
phenotype on Tryptic Soy agar exhibited either a stable or mixed phenotype in the presence 353 
of GSH (Table 2). Thus, as well as increasing the frequency of SCVs, GSH appears to 354 
support the retention of the SCV phenotype. 355 
 356 
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Concluding remarks 357 
Investigation of S. aureus adaptation to aerobic low Eh environments revealed a remodelling 358 
of central metabolism linked to changes in the activities of the redox-responsive transcription 359 
factors AgrA, Rex and SrrA (Fig. 3). The data reported here suggest that aerobic low Eh 360 
environments, such as the host cytosol, switch off AgrA, probably via leakage of electrons 361 
from reduced flavins and quinones to O2, creating reactive oxygen species that promote 362 
formation of an intramolecular disulfide bond in the DNA-binding domain of AgrA [40].  A 363 
more reduced electron transport chain would activate SrrA, which allows stable SCVs to 364 
retain drug-resistance whilst regaining the capacity for rapid growth [11].  The increased 365 
NADH:NAD+ ratios found under aerobic low Eh conditions impair DNA-binding by Rex, 366 
causing derepression of genes associated with fermentative metabolism.  Reducing 367 
environments, that mimic the redox potential of the host cytoplasm, activate the virulence 368 
program of the intracellular pathogen Listeria monocytogenes and it was suggested that this 369 
might be explained, at least in part, by alteration in NADH:NAD+ balance leading to Rex-370 
mediated transcriptional reprogramming [41]. The evidence presented here indicates that 371 
redox-sensing and de-repression of Rex-regulated genes signalled by increased NADH:NAD+ 372 
ratios is a major component of the adaptive response of S. aureus to an aerobic low Eh 373 
environment (Fig. 3).  Hence Rex-mediated transcriptional reprogramming might be a 374 
common feature promoting the survival of Gram-positive pathogens in the host cytosol.  The 375 
increased frequency of SCVs in the presence of GSH implies that intracellular S. aureus 376 
residing in the aerobic low Eh environment of the host cytoplasm is one possible source of 377 
phenotypic SCVs associated with difficult to treat infections.  It is anticipated that these 378 
observations will prompt further work to better understand the role of the low Eh of the host 379 
cytosol in establishing and maintaining persistent infections by facultative and obligate 380 
intracellular pathogens.  381 
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Figure legends 509 
Fig. 1. Staphylococcus aureus USA300 JE2 adapts to an aerobic low redox potential (Eh) 510 
environment imposed by dithiothreitol (DTT) by adopting respiro-fermentative metabolism. 511 
(a-e) Steady-state cultures (1 l) of S. aureus USA300 JE2 were maintained in chemically 512 
defined medium at 37°C and pH 7.0 with constant aeration at 1 l min-1 and a dilution rate of 513 
0.2 l h-1 before perturbation (at time zero) with 9.7 mM DTT. (a) Changes in redox potential. 514 
(b) Changes in dissolved oxygen concentration. (c) Proton-NMR measurements of lactate 515 
concentration in culture supernatants. (d) Lactate dehydrogenase activity of cell-free 516 
extracts. All data shown in these panels are mean values r standard deviation from three 517 
independent experiments. (e) Changes in transcription factor activities in response to 518 
lowering the redox potential of S. aureus cultures were predicted using the TFinfer model 519 
[19].  The input data were the fold changes in expression relative to the initial steady-state 520 
for all the genes present in a binary connectivity matrix that linked 11 transcription factors 521 
(see text) to directly- or indirectly-regulated genes. The output of the model is a time-522 
resolved series of transcription factor activities that could account for the observed changes 523 
in gene expression. The activity of SrrA (circles) was predicted to increase after perturbation, 524 
whereas the activities of AgrA (squares) and Rex (diamonds) were predicted to decrease. 525 
 526 
Fig. 2. The host cytoplasmic reductant glutathione (GSH) inhibits S. aureus USA300 JE2 527 
aerobic respiration, enhances tolerance to gentamicin and increases the frequency of small 528 
colony variant (SCV) formation. (a) Respiratory activity of suspensions of S. aureus in 529 
phosphate-buffered saline (PBS) in a chamber fitted with Clark-type oxygen electrode was 530 
stimulated by the addition of glucose (25 mM; arrow g). Oxygen consumption was followed 531 
and then either potassium cyanide (KCN, 25 mM; light blue trace) or GSH (10 mM; red 532 
trace) were added and the inhibition of respiration relative to suspensions to which 533 
phosphate-buffered saline was added (black trace) was calculated. Treatment with GSH (10 534 
mM) inhibited the rate of oxygen uptake by 32r8%. The data shown are representative of 535 
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three independent experiments. (b) Induction of ldh1 in the presence of GSH. 536 
Staphylococcus aureus RN4220 was transformed with pGS2625, which carries the 537 
superfolder gfp gene under the control of the S. aureus USA300 JE2 ldh1 promoter. Aerobic 538 
batch cultures of the reporter strain were grown in Tryptic Soy broth supplemented with 0.5% 539 
glucose for 3 h at 37°C before addition of GSH (50 mM); control cultures were left untreated.  540 
After overnight incubation, bacteria were washed and suspended to constant OD600 and 541 
GFP was detected by scanning fluorescence spectroscopy.  Typical spectra (GFP emission 542 
at 510 nm; excitation wavelength 485 nm) from triplicate experiments of suspension buffer 543 
(blue trace), untreated cell suspensions (red trace) and GSH-treated cell suspensions (green 544 
trace) are shown.  (c) Growth of S. aureus USA300 JE2 in Luria-Bertani broth (blue trace), 545 
Luria-Bertani broth supplemented with GSH (10 mM; grey trace), Luria-Bertani broth 546 
supplemented with gentamicin (32 Pg ml-1; brown trace) and Luria-Bertani broth 547 
supplemented with both (black trace). (d) Restoration of membrane electrical potential 548 
antagonizes GSH-conferred gentamicin tolerance. Batch cultures of S. aureus USA300 JE2 549 
were grown in triplicate in chemically defined medium containing gentamicin (2 Pg ml-1) in 550 
shaking 96-well plates at 37°C. The medium was supplemented with GSH (10 mM; blue 551 
trace), nigericin (2 nM; orange trace), or both (black trace). The data shown are mean optical 552 
densities (OD595) r standard deviation for three cultures. (d and e) Staphylococcus aureus 553 
USA300 JE2 metabolic mode affects tolerance to gentamicin. Chemically defined medium 554 
agar plates with glucose (15 mM) as the carbon source with and without nitrate (10 mM) 555 
were prepared and soft agar of matching medium seeded with S. aureus were overlaid on 556 
the plates.  Gentamicin (1 mg) was loaded on a central disc and the plates were incubated at 557 
37°C for 24 h before measuring the zones of inhibition (arrows). The images shown are 558 
representative of three experiments. (e) Plates incubated under: aerobic conditions ± aerobic 559 
respiratory growth (left); anaerobic conditions plus nitrate ± anaerobic respiratory growth 560 
(middle); anaerobic conditions ± fermentative growth (right). (f) Plates prepared and 561 
incubated as for (e) but supplemented with GSH (10 mM). (g) Increased frequency of SCVs 562 
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in the presence of GSH and by deletion of the transcription factor, Rex. Six cultures of S. 563 
aureus USA300 JE2 or the corresponding rex mutant were grown in Tryptic Soy broth (TSB) 564 
for 3 h at 37°C.  Glutathione (GSH; 10 mM) was then added to three cultures and all cultures 565 
were incubated for a further hour. Serial dilutions were plated on Tryptic Soy agar (TSA) 566 
containing gentamicin or gentamicin and GSH and the plates were incubated at 37°C for 48 567 
h. The concentration of gentamicin in the plates was 2 Pg ml-1 (G2) and the concentration of 568 
GSH was 10 mM, but the rex mutant (open bars) exhibited enhanced resistance to 569 
gentamicin when GSH was added to the plates and the concentration of gentamicin was 570 
raised to 10 Pg ml-1 (G10).  The chart shows the frequency of SCVs per 108 cells for cultures 571 
unexposed (Broth: TSB; Plate: TSB + G2) and pre-exposed to GSH (Broth: TSB + GSH; 572 
Plate: TSB + G2; or Broth: TSB + GSH; Plate: TSB + G2 or G10 + GSH). The error bars 573 
show the standard deviation from the mean. 574 
 575 
Fig. 3. Working model to account for the adaptation of S. aureus USA300 JE2 to low redox 576 
potential environments. In the cytosol S. aureus encounters an aerobic low Eh environment 577 
imposed by the presence of the reductant glutathione (GSH). Under these aerobic reducing 578 
conditions bacterial aerobic respiration is impaired and electrons leak from the reduced 579 
respiratory chain creating reactive oxygen species (ROS) that inhbit the activity of AgrA 580 
(dashed lines) [40]. The potential DNA damage caused by ROS could be a source of 581 
genotypic SCVs (dashed lines).  Impaired electron transport leads to accumulation of 582 
reduced electron carriers, including menoquinol (MQH2) and NADH. Menaquinol (MQH2) 583 
activates the SrrBA two-component system and elevated NADH:NAD+ ratios inactivate Rex, 584 
permitting expression of lactate dehydrogenase (Ldh1) by activation (o) and derepression 585 
(A), respectively, as well as up-regulation of terminal oxidase (qox and cyd) operons to 586 
partially restore aerobic respiration (Fig. S5). Elevated NADH:NAD+ ratios also inhibit 587 
pyruvate dehydrogenase complex (PDHC) activity, leading to reduction of pyruvate to 588 
lactate, with concomitant oxidation of NADH, through the action of the newly synthesized 589 
25 
 
Ldh1 to ensure that redox balanced growth is achieved. This new mixed metabolic mode is 590 
associated with a lower membrane electrical potential ('<), which impairs uptake of 591 
aminoglycoside antibiotics and hence enhances resistance to gentamicin. These 592 
transcriptional and physiological adaptations are consistent with the characteristics of 593 
phenotypic small colony variants (SCVs). 594 
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Table 1. 7UDQVFULSWVWKDWZHUHDOWHUHGLQDEXQGDQFHE\-fold in response to perturbation of aerobic steady-state cultures of S. 
aureus USA300 JE2 by addition of dithiothreitol 
Gene  Fold-change in transcript abundance at indicated time 
relative to the initial aerobic steady state 
Redox regulator Function 
 2 min 5 min 10 
min 
15 
min 
30 
min 
60 
min 
1440 
min 
  
Amino acids and derivatives 
SAUSA300_0008 
(hutH) 
12.75 13.09 8.33 5.71 4.49 5.22 3.09 AgrA, AirR histidine ammonia-lyase 
SAUSA300_0434 
(metB) 
0.13 0.12 0.11 0.13 0.16 0.12 0.09 CymR cystathionine beta-lyase 
SAUSA300_1227 
(thrC) 
13.45 9.07 3.46 1.63 0.68 1.37 2.57 Rot threonine synthase 
SAUSA300_1228 
(thrB) 
15.60 10.05 3.75 1.92 0.69 1.34 2.50 Rot homoserine kinase 
SAUSA300_1330 
(ilvA) 
1.19 1.31 1.81 1.67 2.57 5.02 28.84 AgrA, AirR threonine ammonia-
lyase 
SAUSA300_1711 
(putA) 
9.23 7.79 5.69 6.04 7.37 7.84 13.37 SrrBA proline dehydrogenase 
SAUSA300_2277 
(hutI) 
21.33 21.40 9.49 5.11 3.81 8.22 5.86 AgrA imidazolonepropionase 
SAUSA300_2278 
(hutU) 
43.22 44.14 12.78 6.86 6.04 15.44 12.85 AgrA uroconate hydratase 
SAUSA300_2491 
(rocA) 
7.34 8.47 9.28 8.48 8.17 7.14 12.42 AgrA, AirR, MgrA, 
Rot 
1-pyrroline-5-
carboxylate 
dehydrogenase 
Biosynthesis of cofactors, prosthetic groups, and carriers 
SAUSA300_0228 
(fadE) 
13.34 7.88 4.60 3.32 3.89 6.12 6.23 AirR, SarZ acylCoA synthetase 
Cell envelope 
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SAUSA300_0315 
(nanA) 
9.93 12.74 9.75 10.42 10.70 12.55 32.68 MgrA N-acetylneuraminate 
lyase 
Anaerobic metabolism 
SAUSA300_0220 
(pflB) 
22.95 55.96 81.10 75.58 59.37 63.09 337.35 Rex, SarZ, SrrBA pyruvate formate-lyase 
SAUSA300_0221 
(pflA) 
11.44 31.64 54.22 52.71 37.10 37.80 189.68 Rex, SarZ, SrrBA pyruvate formate-lyase 
1-activating enzyme 
SAUSA300_0235 
(ldh1) 
13.84 18.55 18.88 15.21 21.59 25.29 123.45 Rex, SrrBA L-lactate 
dehydrogenase 
SAUSA300_0536 
(hchA) 
0.23 0.18 0.10 0.09 0.08 0.08 0.08 AirR, CymR D-lactate 
dehydratase/chaperone 
SAUSA300_0594 
(adh) 
2.3 4.3 4.2 3.8 3.4 6.7 16.7 Rex SrrBA alcohol dehydrogenase 
SAUSA300_2343 
(narG) 
6.47 6.39 3.01 2.26 2.02 4.95 18.38 AirR, NreABC, 
Rex, Rot, SrrBA 
nitrate reductase 
subunit 
SAUSA300_2463 
(ddh) 
9.21 14.22 19.04 26.19 26.46 31.19 69.12 AgrA, AirR, MgrA, 
Rot 
D-lactate 
dehydrogenase 
Carbohydrates ± central metabolism 
SAUSA300_1679 
(acsA) 
21.43 19.54 12.23 10.48 10.53 13.27 24.26 SarZ, SrrBA acetylCoA synthase 
SAUSA300_1331 
(ald) 
1.53 1.56 1.55 1.48 2.70 5.96 27.50 AgrA, AirR alanine dehydrogenase 
SAUSA300_1680 
(acuA) 
9.06 6.70 5.16 5.15 5.18 5.80 14.15 AirR acetoin dehydrogenase  
SAUSA300_1681 8.54 7.45 5.76 5.69 5.25 5.41 13.58 AirR acetylCoA synthetase 
deacetylase 
SAUSA300_1731 
(pckA) 
7.74 8.19 6.79 7.10 9.25 10.47 8.66 AgrA, AirR, SarZ phosphoenolpyruvate 
carboxykinase  
Regulatory functions 
SAUSA300_1989 
(agrB) 
0.23 0.19 0.16 0.14 0.12 0.11 0.08 AgrA, SarA accessory gene 
regulator protein B 
SAUSA300_1990 0.19 0.16 0.13 0.13 0.11 0.10 0.08 AgrA, SarA accessory gene 
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(agrD) regulator protein D 
SAUSA300_1991 
(agrC) 
0.22 0.22 0.17 0.16 0.13 0.13 0.08 AgrA, SarA accessory gene 
regulator protein C 
SAUSA300_1992 
(agrA) 
0.21 0.26 0.21 0.17 0.15 0.16 0.08 AgrA, SarA accessory gene 
regulator protein A 
SAUSA300_2347 
(nirR) 
7.43 6.15 4.49 4.08 4.48 7.52 23.37 AirR, NreABC, 
Rex 
nitrate reductase 
regulator  
Transport and binding proteins 
SAUSA300_0174 
(ssuB) 
0.11 0.09 0.09 0.08 0.10 0.06 0.06 CymR, Rot, SarZ ABC transporter, ATP-
binding protein 
SAUSA300_0333  10.50 10.65 7.04 5.71 2.87 3.03 4.96 AirR PTS system, fructose 
subfamily, IIA 
component 
SAUSA300_0448 
(treP) 
6.11 12.08 10.77 9.11 5.60 5.65 6.63 AgrA, CymR, 
SarZ 
PTS system, trehalose-
specific IIBC component 
SAUSA300_0887 
(oppB) 
14.09 4.82 1.48 1.15 1.13 2.37 2.44  oligopeptide ABC 
transporter, permease 
subunit  
SAUSA300_0888 
(oppC) 
14.64 4.87 1.62 1.22 1.11 2.14 2.46  oligopeptide ABC 
transporter, permease 
subunit  
SAUSA300_0889 
(oppD) 
14.01 6.77 2.22 1.43 0.99 2.19 2.18  oligopeptide import 
ATP-binding protein  
SAUSA300_0890 
(oppF) 
12.58 6.20 2.25 1.38 0.91 1.76 2.00  oligopeptide import 
ATP-binding protein  
SAUSA300_0891 
(oppA) 
11.72 9.97 3.58 1.76 1.10 2.47 1.70  oligopeptide ABC 
transporter, periplasmic 
binding protein 
SAUSA300_0914  12.24 5.26 1.84 1.39 1.23 1.96 1.97 MgrA sodium:alanine 
symporter family protein 
SAUSA300_1329 1.23 1.68 1.67 1.69 2.03 4.35 23.15 AgrA, AirR amino acid permease 
SAUSA300_2313 9.17 13.88 10.11 10.33 13.44 16.08 35.16 Rex L-lactate permease 
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(lctP2) 
SAUSA300_2383 12.77 13.52 12.27 13.69 10.63 8.73 20.50  amino acid permease 
SAUSA300_2449 8.36 11.03 6.57 4.60 4.82 5.10 5.39 AgrA putative MFS 
transporter 
Virulence factors 
SAUSA300_1067 
(psmB1) 
0.04 0.04 0.02 0.02 0.01 0.01 0.00 AgrA, AirR, CymR phenol soluble modulin 
ȕ 
SAUSA300_1068 
(psmB2) 
0.04 0.05 0.04 0.02 0.02 0.01 0.00 CymR phenol soluble modulin 
ȕ 
SAUSA300_1739 17.86 14.37 17.20 17.94 19.07 17.24 47.23 MgrA putative 
immunoglobulin-
blocking virulence 
protein 
SAUSA300_1988 
(hld) 
0.09 0.08 0.05 0.03 0.02 0.01 0.00 AgrA, AirR, SarA RNA-III/delta-hemolysin 
Hypothetical proteins and others 
SAUSA300_0108 2.04 3.45 3.46 3.13 2.79 4.70 10.22 AgrA, AirR, MgrA carbon-oxygen lyase 
(myosin cross-reactive 
antigen) 
SAUSA300_0173 0.19 0.19 0.15 0.13 0.11 0.11 0.07 CymR, Rot, SarZ  
SAUSA300_0227 
(fadD) 
26.45 23.40 12.99 12.14 5.89 10.16 9.83 AirR, SarZ cyclohexanecarboxyl-
CoA dehydrogenase 
SAUSA300_0228 
(fadE) 
13.34 7.88 4.60 3.32 3.89 6.12 6.23 AirR, SarZ acylCoA synthetase 
SAUSA300_0229 
(fadX) 
10.78 9.51 5.16 3.81 3.22 3.79 5.35 AirR, SarZ putative acylCoA 
transferase 
SAUSA300_0311 5.27 4.95 3.92 6.99 5.35 11.06 27.96  ribokinase 
SAUSA300_0312 
(psuG) 
4.41 5.01 5.40 6.90 6.30 10.11 27.60  hypothetical protein 
SAUSA300_0862 
(glpQ) 
8.27 10.39 10.75 9.97 9.26 9.98 35.01  glycerophosphoryl 
diester 
phosphodiesterase 
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SAUSA300_1224 5.14 7.06 5.83 5.64 6.93 8.16 13.88 AirR hypothetical protein 
SAUSA300_2132 10.70 19.23 21.67 13.73 13.65 14.09 13.77  hypothetical protein 
SAUSA300_2164 0.27 0.26 0.18 0.15 0.12 0.10 0.08 AgrA, AirR, 
CymR, SarA 
hypothetical protein 
SAUSA300_2423 18.18 19.72 25.19 26.99 30.41 33.81 143.61 Rot hypothetical protein 
          
aRedox responsive regulators are assigned on the basis of gene expression data [23-32]. 
 
31 
 
Table 2. Glutathione increases retention of the SCV phenotype.   
  Patches with the indicated phenotypea 
   Tryptic Soy agar 
  Unstable Mixed Stable 
Tryptic Soy 
agar plus 
GSH 
Unstable 20 1 0 
Mixed 6 35 7 
Stable 7 66 68 
aTwo hundred and ten S. aureus JE2 USA300 SCVs were picked from Tryptic Soy 
agar plates containing gentamicin (2 Pg ml-1).  Each SCV was sequentially patched 
on to Tryptic Soy agar containing 10 mM GSH and Tryptic Soy agar alone.  The 
plates were incubated for 3 days at 37°C and then the phenotypes were recorded: 
Unstable, reversion to normal phenotype; Mixed, patches were a mixture of normal 
and SCV phenotypes; Stable, SCV phenotype maintained.  A representative pair of 
plates is shown in Fig. S4.   
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